NYSEFinancialsCapital MarketsSnapshot 2026-07-31
Reading MS? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Investment Banking & Brokerage is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Net revenues reach about $70.6 billion: metric not reported.
View ThesisRevenue growth is slowing — up about 10% over the past year and decelerating.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 27%, softest on free-cash-flow margins.
View QualityManagement screens strong on capital allocation, earnings delivery, margins.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskMorgan Stanley's growth in investment banking and trading must continue to justify its price. Revenue grew 27% year over year, and the latest earnings beat expectations. It trades at 17× P/E, below the peer median of 21×. This suggests the price reflects less growth than expected. A risk is that guidance could be cut, with a 16% chance of missing next quarter. Peer multiples imply a price about 15% below where it trades. This read is provisional.
Trailing returns as of 2026-07-31. MS is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 26 analysts currently covering MS (as of Jul 2026).
Based on 4 Wall Street analysts offering 12-month price targets for MS in the last 4 months.
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-08-01. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Investment Banking & Brokerage — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Allegations could affect reputation and earnings performance.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-31. EPS is implied from price ÷ P/E. Not investment advice.
Current $210.51
The last 12 months of price, then the range of analyst 12-month targets from today’s $210.51.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Threatens: Increase quarterly common stock dividend
New debt issuance may affect dividend sustainability.
Indicates resilience in earnings performance.
Advances: Deliver strong quarterly earnings performance
Strong Q1 results support earnings performance objective.
Advances: Deliver strong quarterly earnings performance
Strong verdict supports Morgan Stanley's earnings performance outlook.
Pressure on mortgage staff could impact earnings performance.
Pressure on bankers could impact reputation and operations.
Pressure on bankers could impact reputation and operations.
